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A B S T R A C T
Introduction: Lichen planus is a chronic skin and oral mucosa disease. Coexistence of the oral form of lichen 
planus with diabetes and hypertension was described for the first time by Grinspan in 1963.
Case description: Two cases of the occurrence of lichen planus in patients with diagnosed diabetes and hyperten-
sion (Grinspan’s syndrome) are presented. In the first case, diabetes and hypertension treatment were accompanied 
by lesions in the oral cavity and on the skin of shins. In the other case, lichen planus type lesions were manifested only 
in the oral cavity.
Conclusions: The aetiology of lichen planus remains unclear to some extent. Detailed diagnostics is based on 
clinical examination, general medical history and histopathological findings. The risk of malignant transforma-
tion of oral lichen planus ranges from 0.4 to 5.3% and it regards mainly the erosive form. Regular follow-up visits 
and oncological vigilance constitute an inseparable part of treatment.
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INTRODUCTION
Lichen planus (LP) is a chronic inflammatory auto-
immune disease of skin and oral mucosa, which affects 
stratified squamous epithelium of the skin and oral mu-
cosa. It may progress with exacerbations and remission 
periods [1-3]. 
It is a  relatively frequent disease affecting 0.1-2.0% 
of the population [4], occurring in people aged 30 to 70. 
In about 60% of  cases it affects women  [5], although 
some authors indicate higher male predilection  [6, 7]. 
It is spread globally and it may vary depending on race 
and geography [4, 7].
The causes and pathogenesis of LP remain unclear, 
but some evidence shows that it is an  immunological 
disorder, in which T lymphocytes show activity towards 
the epithelial antigen [8]. Such reaction is histologically 
proximate to the  immune response of  a  chronic graft-
versus-host disease (cGVHD)  [8, 9]. The  histopatho-
logical evaluation of  early lesions of  oral LP indicates 
the prevalence of T helper lymphocytes (CD4+), where-
as in advanced forms T cytotoxic lymphocytes (CD8+) 
are prevalent  [10]. Other likely etiological factors in-
clude infection (virus, including HCV, ca. 5.4%), meta-
bolic (vitamin deficiencies), genetic and psycho-neuro-
genic factors [10-14].
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Lesions may involve skin and mucous membranes. 
According to Jańczuk, lesions involve the oral cavity in 
50% of  people with skin lesions. There are also cases 
of  lesions occurring on the genital mucosa [3, 15, 16]. 
Isolated oral lichen planus (OLP) can be observed in 
13-53% of  cases. The most frequent location of  lesions 
in the oral cavity is cheeks, tongue, lips and gums. Also 
characteristic is the usually symmetric and bilateral lo-
cation of such lesions [3, 17].
The clinical picture of OLP varies. The basic lesion 
is a papule, yet intraoral lesions may range from white, 
tree-shaped, asymptomatic forms, to painful erosions 
and ulcerations surrounded by papules [18]. Andreasen 
distinguished 6 forms: follicular, reticular, plaque-like, 
atrophic, erosive and bullous. This classification has 
been accepted by the WHO. A  follicular, reticular and 
plaque-like form is referred to as the “white lichen pla-
nus”, whereas an erosive, atrophic and bullous form is re-
ferred to as the “red lichen planus”. The most frequent is 
the reticular form with numerous overlapping keratotic 
lines or stripes, the so-called Wickham striae. Knychal-
ska-Karwan differentiates between a simple and a com-
plex form, whereas Jańczuk enumerates tree-shaped, cir-
cinate (lichen annularis), atrophic (lichen atrophicus), 
hypertrophic (lichen hypertrophicus), confluencing 
(lichen confluens), and bullous (lichen pemphigoides) 
forms [3, 5, 19-21].
In clinical practice, one may use a simplified version 
of OLP classification proposed by Bagan-Sebastian, in-
dicating two forms: reticular – R (only with the presence 
of white striae or papules) and more advanced atrophic 
− erosive-AE (with erosions and blisters) [21, 22].
Lesions in alveolar gingiva in the course of OLP in-
dicate the presence of desquamative gingivitis, which is 
observed in 25% of  cases and most frequently it con-
cerns women (72.9%)  [23]. A  characteristic symptom 
of active forms of  the disease is the so-called Köbner’s 
phenomenon, which is a  response to mechanical irri-
tation. Clinical manifestation of  the  Koebner response 
is the occurrence of some reaction in the form of pap-
ules in the place of a mechanical stimulus within 7-14 
days [24, 25].
Skin lesions in the course of LP accompany symp-
toms in the oral cavity in 30% of patients. Predilection 
to the occurrence of lesions is indicated by the internal 
surface of wrists, thighs, the lumbar region and the front 
shin surface, and similarly to the oral form, lesions fre-
quently occur symmetrically. They may have the  form 
of  itching reddish papules, 3-4 mm in diameter, and 
with time they increase, amalgamate and change colour 
to bluish-purple, violet or brown [3, 5, 24].
Diagnostic difficulties with unambiguous characteri-
sation of the OLP pattern may be caused by lesions which 
clinically can suggest LP. These are the  so-called oral 
lichenoid lesions (OLL), described for the  first time by 
Almeyda & Levantine in 1971 [26]. There are certain clin-
ical and histological features which make it possible to dis-
tinguish a lichenoid reaction from classical LP. Lichenoid 
lesions are distinguished by a  tendency to occur unilat-
erally and their development, contrary to the idiopathic 
OLP background, is closely related to the activity of well-
known chemical compounds, such as mercury (present 
in amalgam fillings), gold, composite materials or acryl. 
It is interesting that lichenoid lesions can be induced by 
systemic pharmacotherapy, with a particular emphasis on 
non-steroidal anti-inflammatory drugs (NSAID), angio-
tensin drugs, beta blockers, cardiac glycosides, antima-
larial drugs, sulfasalazine, sulphonylurea components, 
diuretics, as well as antidiabetic drugs [26-31]. Remission 
of lesions within 2-3 months after removing a causal fac-
tor or after discontinuation of drugs suggests the clinical 
diagnosis of a  lichenoid lesion [32]. A decisive test, en-
abling final diagnosis, is histopathological verification. In 
the histopathological picture, in the case of LP, a charac-
teristic shape of epithelium structures looking like “saw 
tooth” is identified. Hyper- and parakeratosis, keratino-
cyte degeneration of  the epithelium basal layer, damage 
of elastic and collagen fibres, as well as inflammatory cells 
(lymphocytes, histiocytes and mast cells) are observed 
concurrently  [32-35]. An  immunofluorescence test may 
turn out helpful in distinguishing between OLP and OLL. 
Direct immunofluorescence shows linear concentration 
of  IgM, IgA deposits and complement component C3, 
along the basal membrane in the case of both OLP and 
lichenoid lesions  [36]. In indirect immunofluorescence 
in the  case of  drug-induced lesions, a  picture of  anti-
bodies arranged like a “string of pearls” is characteristic  
[30-32] (Table 1).
Grinspan’s syndrome is characterised by the occur-
rence of a triad of symptoms: LP, diabetes and hyperten-
sion. This syndrome was observed by Grinspan and his 
associates, who presented coincidence of the erosive LP 
with hypertension and diabetes, and the results of their 
studies were announced at the Dermatology Congress in 
Buenos Aires in 1963. Grupper and Avul’s studies seemed 
to confirm the existence of that symptomatologic triad, 
called by the authors “Grinspan’s syndrome” [37]. Other 
TABLE 1. Modified World Health Organization criteria 
for the diagnosis of oral lichenoid lesions and oral lichen 
planus (according to [6])
Clinical criteria
•	Bilateral occurrence of more or less symmetrical pathological lesions
•	Presence of white striae (or reticulum pattern)
•	Erosive, atrophic, bullous and plaque-like forms are considered 
subtypes when they accompany the reticulum occurrence in other areas 
of mucosa
Histological criteria
•	 Infiltration consisting of lymphocytes in the surface layer of connective 
tissue
•	Signs of degeneration in the base layer of epithelium
•	No epithelial dysplasia 
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authors link more frequent occurrence of  LP lesions 
in patients with hypertension or diabetes to the  drugs 
used by them. In this situation, Lamey and associates 
suggested that Grinspan’s syndrome may be iatrogeni-
cally induced, whereas lesions in the oral cavity are only 
a  lichenoid reaction in response to systemic treat-
ment  [3, 32]. The  proper mechanism of  drug-induced 
OLP pathogenesis remains unclear. One of  theories 
indicates damage of  keratinocytes of  the  epithelium 
basal layer with antibody creation  [38]. A  certain link 
is also suggested between endocrinological disorders in 
the course of diabetes and the occurrence of immuno-
logical defects contributing to OLP development [39].
The goal of this study was to present a treatment pro-
tocol and results of patients with OLP lesions, who un-
derwent systemic treatment in the course of diagnosed 
diabetes and hypertension (Grinspan’s syndrome).
CASE DESCRIPTION
CASE 1
Patient A.D., 68 years old, was referred by a dental pros-
thetics specialist in order to diagnose and treat lesions on 
the oral mucosa. Lesions were discovered during routine 
dental examination before the  planned prosthetic treat-
ment. Reported disorders included the  sense of  dryness 
of the mouth and periodic discomfort in the buccal mu-
cosa, particularly intense when eating sour and spicy food.
A general medical history provided information about 
coexisting general diseases, namely hypertension diag-
nosed in 1992 (treated with Betaloc ZOK 100 mg: 1-0-0, 
Tritace 2.5 mg: 0.5-0-0) and type 2 diabetes diagnosed in 
1993 (Siofor 850 mg: 0-0-2, Glibetic 3 mg: 1-0-0).
Additionally, the  interview provided information 
about myocardial infarction suffered in 2007 and about 
permanent dermatological treatment of  a  skin form 
of  LP with Lorinden (3 times a  day). Dermatological 
treatment had been conducted for about 3 years. The pa-
tient mentioned itching of  skin lesions and the  occur-
rence of new lesions in the place of irritation. The patient 
did not smoke and consumed alcohol only occasionally.
Extraoral clinical examination of the face skin did not 
show any lesions. Lymph nodes were not painful and were 
undetectable in palpation. On the skin of the left shin pur-
plish red papules of different sizes (2-30 mm) were report-
ed, with a shiny surface, with poorly marked small white 
lines, the so-called Wickham striae (Figures 1 and 2).
In the intraoral clinical examination, interdental gaps 
were found in the maxilla and the mandible: class IV ac-
cording to the  Galasińska-Landsberger classification. In 
Eichner’s classification: B3. For about 7 years, the patient 
had used a partial upper acrylic prosthesis and a partial 
lower prosthesis. In the  area of  prosthetic restorations 
they were found not sufficiently in contact with the pros-
thetic base. The hygiene of the oral cavity and restorations 
was evaluated as poor. A few cavities due to caries were 
visible, together with advanced pathological teeth abra-
sion and sharp tooth edges and fillings. No amalgam fill-
ings were found.
A clinical examination of  buccal mucosa showed 
the presence of white lines and striae mingling in irreg-
ular tree and ring shapes (Figures 3 and 4) and desqua-
mative gingivitis in the area of incisors in the mandible 
FIGURE 1. Lichen planus – follicular rash on the skin 
of shins
FIGURE 2. Lichen planus – follicular rash on the skin 
of shins
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(Figure 5). Mucosa surrounding the  lesions did not 
show any visible pathological features.
Advanced horizontal alveolar ridge atrophy of the 
maxilla and the alveolar part of the mandible was found 
radiologically. Teeth 11 and 21, 36 – status after end-
odontic treatment, with a  shadow of  contrast material 
for radiological apexes.
On the basis of clinical examination, the initial di-
agnosis was formulated, being a reticular (simple) form 
of OLP. Supplementing the physical examination with 
data obtained from the patient’s medical history, stat-
ing coexistence of  diabetes and hypertension, as well 
as systemic hypotension and hypoglycaemic treatment, 
the  initial diagnosis of  Grinspan’s syndrome was put 
forward.
Due to the  likelihood of  a  possibility of  the  Koeb-
ner response occurrence, topical treatment started with 
the  elimination of  irritating agents. To this end, sharp 
edges of teeth and composite fillings were smoothened, 
scaling with polishing was performed, together with 
providing instructions on how to take care of  the  hy-
giene of the oral cavity and prosthetic restorations. Due 
to the  presence of  caries, the  patient was referred for 
conservative treatment.
On the  basis of  subjective complaints found in 
the  medical history, being the  feeling of  irritation and 
dryness in the oral cavity, a smear from the oral muco-
sa was ordered to make a microbiological test, together 
with determining sensitiveness to drugs.
Topical treatment of oral mucosa, covering the time 
of  supplying results of  additional tests, included using 
neutralising mouthwash (4% sol. aq. Natrium bicarbon-
icum, 3 times a day) diluted in the proportion: 1 spoon 
in one glass of water. After 14 days, the test result was 
received, in which abundant growth of a Candida kefyr 
colony was identified, sensitive to miconazole, nystatin 
and itraconazole. It was recommended to continue us-
ing the neutralising mouthwash (3 times a day) and anti-
fungal treatment was implemented due to the sensitivity 
of the strain to the drugs. To this end, local application 
of  gel with miconazole (Daktarin oral) was prescribed 
3 times a day. The patient received dietary recommen-
dations, including reduction of  monosaccharide con-
sumption, elimination of hot and sour meals, as well as 
avoidance of hot spices.
A follow-up visit was appointed after 14 days. 
The  sense of  dryness and irritation decreased signifi-
cantly. The condition of mucous membrane and skin le-
sions remained unchanged. Local treatment was contin-
ued for 6 weeks. Two weeks after finishing the antifungal 
treatment, the  therapeutic effectiveness evaluation was 
performed by making a check-up smear.
After 10 weeks from initiating the  local treatment, 
the  patient provided the  smear result with a  negative 
culture result for yeast-like fungi. He reported disap-
pearance of irritation and dryness in the oral cavity. In 
clinical examination, continuous persistence of  white 
lesions on the oral mucosa was identified and brownish 
papules on the left shin skin. Due to the nature of the le-
sions, i.e. a  reticular form, lack of erosions and the  le-
sions location, no direct indication for histopathologi-
cal verification was identified at this stage of treatment. 
The patient did not consent to biopsy because of his old 
age and lack of  severe pain. Maintenance therapy in-
cluded using neutralising mouthwash alternatively with 
herbal wash with a  protective and anti-inflammatory 
FIGURE 3. Lichen planus – reticular form on the buccal 
mucosa
FIGURE 4. Lichen planus – reticular form on the buccal 
mucosa
FIGURE 5. Lichen planus – desquamative gingivitis
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effect (linseed, mallow flower, chamomile and marsh-
mallow). The patient awaits further follow-up. He comes 
regularly every 3 months. Lesions in the oral cavity and 
on the skin persist. Periods of exacerbation do not occur. 
He waits for new prosthetic restorations.
CASE 2
A 57-year-old patient, R.R., visited a  doctor due to 
white lesions on the buccal mucosa. The lesions had been 
seen by a dentist about 4 weeks before, during a routine 
check-up examination. The lesions were accompanied 
with the  feeling of  dryness and irritation of the oral 
cavity.
It stemmed from the  medical history that the  pa-
tient had been treated by a cardiologist since 2005, due 
to diagnosed hypertension (treated with Co-Amlessa 
8 mg/10 mg/2.5 mg: 1-0-0) and was also regularly treated 
by a diabetologist for type 2 diabetes diagnosed in 2005 
(Clucophage 750 mg: 1-0-0, NovoRapid Penfill 100 j./ml: 
1-0-0, Insulatard Penfill – before a  meal). Since 2006, 
he has also been treated for dyslipidemia (Ridlip 20 mg: 
1-0-0). The patient is on a low-fat diet based on a low gly-
cemic index. He used to smoke cigarettes, but ceased about 
3 years ago.
Extraoral clinical examination was without any tan-
gible pathology.
In an intraoral examination, anodontia in the maxilla 
and interdental gaps and posterior teeth loss in the man-
dible were identified. According to the Galasińska-Lands-
bergerowa classification it is class V in the maxilla, and 
class IV in the mandible. According to the Eichner clas-
sification, losses were identified as C2. The patient had 
used a total acrylic prosthesis in the maxilla and a par-
tial acrylic prosthesis in the mandible for about 3 years. 
The analysis of prostheses showed close fitting and adhe-
sion to the prosthetic base. 
The clinical examination was supplemented with 
radiological diagnostics. Based on an  orthopantomo-
graphic image, advanced bone atrophy in the  maxilla 
and the mandible was identified. Tooth 34 – condition 
after endodontic treatment with a  shadow of  contrast 
material to the radiological apex.
In the  physical examination of  the  buccal mucosa, 
numerous symmetric milky-white streaks with tree-
shaped outlines were found, the image of which resem-
bled a reticular form of Wilson’s LP (Figures 6 and 7). At 
the same time, in the area of the toothless alveolar part 
of  the  mandible, in the  molar and retromolar region, 
in the immediate proximity of buccal lesions, extensive 
uniform fields of opacity were visible with an opalescent 
surface, the clinical image of which suggested leukopla-
kia (Figure 8). In the remaining parts of the oral cavity 
no pathological lesions were observed. After the  an-
amnesis, physical examination and thorough analysis 
of the course of general diseases and the systemic phar-
macological treatment performed, initially, Grinspan’s 
syndrome was diagnosed within the scope of lesions on 
the buccal mucosa with a triad of symptoms: LP, hyper-
tension and diabetes. Taking into account a  long-term 
tobacco smoking addiction, a characteristic image and 
location of uniform opacities on the cornified gingiva, 
the initial diagnosis was as follows: homogeneous leuko-
plakia of the molar and retromolar region of the tooth-
less alveolar part of the mandible.
The local treatment of lesions on the alveolar gingiva 
and buccal mucosa was applied by means of  an  aque-
FIGURE 8. Leukoplakia of the toothless alveolar part 
of the mandible in the molar and retromolar region
FIGURE 6. Lichen planus – reticular form on the buccal 
mucosa
FIGURE 7. Lichen planus – reticular form on the buccal 
mucosa
Journal of Stomatology * http://www.jstoma.com454
Kamila Grabowska-Szeląg, Izabella Tomera-Niekowal, Barbara Kęsek
ous solution of  vitamin A  + D3 (3 times a  day) and 
neutralising mouthwash (4% sol. aq. Natrium bicarbin-
icum). A smear was ordered for a microbiological test 
of  the oral mucosa. The patient was also instructed on 
hygiene, taking into account prosthetic restorations. 
The  information was provided about indications for 
histopathological verification of  the  clinical diagnosis 
of leukoplakia. A follow-up visit took place 3 weeks after 
conducting local treatment. The patient had a negative 
result of the microbiological culture.
Clinically, slight reduction of white lesions on the al-
veolar part of  the  mandible was reported. The  condi-
tion of  the  buccal mucosa did not improve noticeably. 
Continuation of swabbing of lesions on the alveolar part 
of  the  mandible with an  aqueous solution of  vitamin 
A  + D3 was recommended. Gel with tannin (Salumin) 
was prescribed to swab the buccal mucosa 3 times a day. 
The next visit was appointed after 2 months. Lesions on 
the alveolar gingiva disappeared completely, but the  le-
sions on the  buccal mucosa with a  characteristic tree-
shaped clinical image, corresponding to LP (a reticular 
form), persisted. Due to extensive lesions, it was clinical-
ly impossible to exclude unambiguously the co-existence 
of  LP lesions with leukoplakia-type lesions, so a  fully 
conscious decision was made, with the patient’s consent, 
to verify it histopathologically. In local anaesthesia with 
a  4% solution of  Articaine hydrochloride + epineph-
rine (Ubistesin forte), a sample tissue was collected with 
a margin of healthy tissue, and the wound was sewn with 
non-absorbable, synthetic sutures (Prolene 5.0). The col-
lected material was sent to a histopathological laboratory. 
Sutures were removed after 7 days. Microscopic evalu-
ation of  the  collected bioptate indicated the  presence 
of  hyper- and parakeratosis, degeneration of  keratino-
cytes and inflammatory infiltration, together with confir-
mation of the initial clinical diagnosis of LP. Local protec-
tive treatment of lesions on the buccal mucosa (Salumin 
and neutralising mouthwash) was continued. The patient 
attended follow-up visits every 3 months. Although sys-
temic drugs remained unchanged, preservation of good 
hygiene of the oral cavity and prosthetic restorations, as 
well as local protective treatment, had an impact on con-
siderable reduction of lesions in the oral cavity. The pa-
tient was told to make an urgent appointment if lesions in 
the oral cavity worsened or if the disease evolved.
DISCUSSION
The occurrence of intraoral lesions of the LP in pa-
tients with hypertension and diabetes was described for 
the first time by Grinspan et al. in 1963, and subsequent-
ly called Grinspan’s syndrome. Some authors question 
the existence of this disease, linking more frequent oc-
currence of LP lesions in patients with hypertension or 
diabetes with the drugs they take [40]. Data from liter-
ature show that a considerable number of drugs taken 
during systemic diseases may contribute to intraoral 
lesions, which clinically may conform with the  image 
of LP [26-32, 40]. It enabled separation of OLL, which 
might be a disease in themselves, and those which might 
result from exacerbation of OLP in response to the drugs 
taken. The study of Habbab et al. showed the occurrence 
of lichenoid lesions in 3.6% of patients taking drugs for 
cardiovascular disorders [41]. It is not always possible to 
change medication. In justified cases, it may be done in 
consultation with the practitioner.
In a differential diagnosis of the reticular form of LP, 
one needs to take into consideration also such lesions 
as naevus spongiosus albus, lesions relating to a chronic 
habit of biting or retracting the oral mucosa, lesions in lu-
pus erythematosus, candidosis or GVHD. On the other 
hand, manifestation of oral diseases with an autoimmu-
nological background, such as pemphigus, pemphigoid 
or lupus erythematosus, can be erroneously diagnosed 
as an erosive or atrophic form of LP [1, 5, 14, 27].
Patients with a  diagnosed Grinspan’s syndrome 
should be treated regularly by a diabetologist, cardiolo-
gist and dermatologist (in the case of manifested skin le-
sions). Regular visits to the Oral Mucosal Diseases Clin-
ic every 3 months should supplement interdisciplinary 
cooperation, due to a  risk of  transformation of  simple 
LP lesions into complicated forms, frequently induced 
by stress, dietary negligence, mechanical irritation, drug 
changes or exacerbation of general diseases. Special at-
tention is required in the case of patients suffering from 
the  erosive form of  LP, which has been referred to by 
the WHO as a precancerous condition [35, 44]. A pos-
sible complication on the basis of the erosive form of LP 
is the development of oropharyngeal squamous cell car-
cinoma (OSCC). The  risk of  malignancy ranges from 
0.4 to 5.3% [19, 43, 44]. According to Knychalska-Kar-
wan, in patients with lichen the risk of malignant trans-
formation is 10-20 times higher than in the  average 
population  [3]. Dynamic lesions and those resistant to 
the local treatment require histopathological verification, 
according to the so-called golden 2-week principle [45].
Simple forms of LP are often without any symptoms 
and they do not require any pharmacological interven-
tion. An important aspect of treating OLP is informing 
the  patient properly about the  chronic nature of  this 
disease. Although typical cases of skin LP are often sub-
ject to remission, oral lichen withdraws only in some 
patients  [19]. The  basis for implementing treatment 
of the lesions should be determined based on thorough 
anamnesis and physical examination and, if possible, 
confirmed with a  histopathological test  [32, 37, 45]. 
Local irritating agents, with special emphasis on dental 
deposits (tartar), sharp edges of fillings and prosthetic 
restorations should be eliminated. An important aspect 
is to modify the diet, excluding hot, salty, spicy and hard 
food  [26, 31]. Information from the  medical history 
with regard to subjective symptoms in the form of irri-
tation and dryness of the oral cavity is indicative of per-
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forming microbiological tests, since data from the  lit-
erature indicate a  high percentage (30-50%) of  fungal 
infection overlapping with lesions due to LP [5, 46]. In 
the case of a reticular form of OLP, protective treatment 
by means of herbal infusions (linseed, marshmallow and 
mallow flower) is recommended, together with regular 
visits every 2-3 months  [31, 47, 48]. In more complex 
forms of  OLP (including bullous and erosive forms), 
positive effects are achieved as a result of local treatment 
with 0.1% tacrolimus. In the local treatment of keratot-
ic lesions it seems appropriate to implement retinoids, 
due to their capability of regulating keratotic and kerat-
inocyte differentiation processes, facilitating exfoliation 
of  dead cells, reducing inflammation and stimulating 
collagen and angiogenesis synthesis. In advanced forms, 
local administration of  steroids is sometimes neces-
sary [26, 31, 46, 49, 50].
CONCLUSIONS
In both cases presented above, a  triad of  symptoms 
characteristic for Grinspan’s syndrome was identified. In 
the  first case, confirmation of  the  syndrome was based 
only on clinical diagnosis of oral LP and data from med-
ical history confirming the  skin form of LP, whereas in 
the  second description, the  clinical diagnosis was addi-
tionally confirmed histologically. Regardless of  the kind 
of  intraoral lesions, the practitioner should be oncolog-
ically vigilant. Long-term observations are necessary to 
monitor lesions and potential malignant transformations.
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